| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Division of Viral Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland
Requests for reprints: Betsy J. Barnes, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, 1650 Orleans Street, Baltimore, MD 21231. Phone: 443-287-2758; Fax: 410-955-0840; E-mail: barnebe{at}jhmi.edu.
Human IFN regulatory factor-5 (IRF-5) is a candidate tumor suppressor gene that mediates cell arrest, apoptosis, and immune activation. Here we show that ectopic IRF-5 sensitizes p53-proficient and p53-deficient colon cancer cells to DNA damage–induced apoptosis. The combination IFN-ß and irinotecan (CPT-11) cooperatively inhibits cell growth and IRF-5 synergizes with it to further promote apoptosis. The synergism is due to IRF-5 signaling since a striking defect in apoptosis and cell death was observed in IRF-5-deficient cells, which correlated well with a reduction in DNA damage–induced cellular events. Components of this IRF-5 signaling pathway are investigated including a mechanism for DNA damage–induced IRF-5 activation. Thus, IRF-5–regulated pathways may serve as a target for cancer therapeutics.
This article has been cited by other articles:
|
|
 |
|
  S. Sigurdsson, G. Nordmark, S. Garnier, E. Grundberg, T. Kwan, O. Nilsson, M.-L. Eloranta, I. Gunnarsson, E. Svenungsson, G. Sturfelt, et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5 Hum. Mol. Genet., September 15, 2008; 17(18): 2868 - 2876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xu, L. Zhao, L. Del Valle, J. Miklossy, and L. Zhang Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes J. Virol., July 1, 2008; 82(13): 6251 - 6258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Ronnblom and V Pascual The innate immune system in SLE: type I interferons and dendritic cells Lupus, May 1, 2008; 17(5): 394 - 399. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Bailey, D. E. Abbott, N. V. Margaryan, Z. Khalkhali-Ellis, and M. J. C. Hendrix Interferon Regulatory Factor 6 Promotes Cell Cycle Arrest and Is Regulated by the Proteasome in a Cell Cycle-Dependent Manner Mol. Cell. Biol., April 1, 2008; 28(7): 2235 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Couzinet, K. Tamura, H.-m. Chen, K. Nishimura, Z. Wang, Y. Morishita, K. Takeda, H. Yagita, H. Yanai, T. Taniguchi, et al. A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis PNAS, February 19, 2008; 105(7): 2556 - 2561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yanai, H.-m. Chen, T. Inuzuka, S. Kondo, T. W. Mak, A. Takaoka, K. Honda, and T. Taniguchi Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression PNAS, February 27, 2007; 104(9): 3402 - 3407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-F. Cheng, S. Brzostek, O. Ando, S. Van Scoy, K. P. Kumar, and N. C. Reich Differential Activation of IFN Regulatory Factor (IRF)-3 and IRF-5 Transcription Factors during Viral Infection. J. Immunol., June 15, 2006; 176(12): 7462 - 7470. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
